A novel thromboxane A2 receptor N42S variant results in reduced surface expression and platelet dysfunction

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Thromboxane receptor (TP) variants are linked to bleeding disorders and platelet dysfunction.
• A conserved asparagine residue is critical for class A G protein-coupled receptor (GPCR) structure and function.

Observation:

• A patient with a bleeding history presented with a novel heterozygous TP receptor variant (N42S).
• Platelet aggregation studies revealed impaired arachidonic acid response and altered U46619 concentration-response curves in the patient.
• Calcium mobilization assays and radioligand binding demonstrated reduced receptor function and surface expression of the N42S variant.

Findings:

• The N42S substitution in the thromboxane receptor leads to significant platelet dysfunction.
• Reduced surface expression of the TP receptor is the primary mechanism underlying the observed platelet dysfunction.
• This is the first reported naturally occurring variant affecting this highly conserved asparagine residue.

Implications:

• The N42S variant provides critical insights into TP receptor structure-function relationships.
• Understanding this variant's impact can aid in diagnosing and managing bleeding disorders.
• This discovery underscores the importance of conserved residues in GPCRs for maintaining normal physiological function.